Wenjia Zhu

Changchun Street
Beijing, 100053, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Spatiotemporal Dynamics and Cellular States of Neuroinflammation in Amyotrophic Lateral Sclerosis: Implications for Stage‑Specific Therapeutics.

Spatiotemporal Dynamics and Cellular States of Neuroinflammation in Amyotrophic Lateral Sclerosis: Implications for Stage‑Specific Therapeutics.

Journal: ASN neuro

Published: August 18, 2026

Regional dopaminergic dysfunction patterns discriminate Parkinson's disease from multiple system atrophy parkinsonian subtype.

Regional dopaminergic dysfunction patterns discriminate Parkinson's disease from multiple system atrophy parkinsonian subtype.

Journal: Clinical parkinsonism & related disorders

Published: December 17, 2025

Clinical and laboratory features of juvenile-onset anti-NF155 autoimmune nodopathy.

Clinical and laboratory features of juvenile-onset anti-NF155 autoimmune nodopathy.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 26, 2025

Association of Demographic, Clinical, and Environmental Factors With Disease Severity in Adult Myasthenia Gravis: A Multicenter Cross-Sectional Study.

Association of Demographic, Clinical, and Environmental Factors With Disease Severity in Adult Myasthenia Gravis: A Multicenter Cross-Sectional Study.

Journal: CNS neuroscience & therapeutics

Published: July 25, 2025

Efficacy of Tacrolimus Plus Prednisone as Long-Term Immunosuppressive Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: A Retrospective Cohort Study.

Efficacy of Tacrolimus Plus Prednisone as Long-Term Immunosuppressive Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: A Retrospective Cohort Study.

Journal: ImmunoTargets and therapy

Published: June 06, 2025

Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and Safety.

Tacrolimus as Single-Agent Immunotherapy for Adult-Onset Myasthenia Gravis: Remission, Relapse, and Safety.

Journal: CNS neuroscience & therapeutics

Published: May 24, 2025

Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational study.

Factors associated with early response to efgartigimod in patients with generalized myasthenia gravis: a multicenter retrospective observational study.

Journal: Journal of neurology

Published: April 29, 2025

Rhabdomyolysis associated with OBSCN mutations: case report and mechanistic review.

Rhabdomyolysis associated with OBSCN mutations: case report and mechanistic review.

Journal: Neuromuscular disorders : NMD

Published: April 17, 2025

Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia Gravis.

Dynamic Changes in Peripheral Immune Cells During Efgartigimod Treatment in Naive Generalized Myasthenia Gravis.

Journal: CNS neuroscience & therapeutics

Published: April 14, 2025

Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis.

Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis.

Journal: Journal of autoimmunity

Published: February 24, 2025

Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients.

Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients.

Journal: Therapeutic advances in neurological disorders

Published: October 01, 2024

The Impact of COVID-19 Vaccination and Infection on the Exacerbation of Myasthenia Gravis.

The Impact of COVID-19 Vaccination and Infection on the Exacerbation of Myasthenia Gravis.

Journal: Vaccines

Published: September 24, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026